Exela Technologies, Inc. Reports Fourth Quarter and Full Year 2018 Results; Digital Now℠ Powering Growth
Fourth Quarter 2018 Highlights:
- Revenue of
$399.6 million , representing 3.4% growth over Q4 2017 - Operating loss of
($39.2) million , representing an improvement of$12.0 million over Q4 2017 - Net loss of
$84.4 million - EBITDA(1) of
($6.6) million , representing an improvement of$14.5 million over Q4 2017 - Adjusted EBITDA(2) of
$75.3 million , representing 20.0% growth over Q4 2017 - Achieved
$15.7 million of savings during the fourth quarter of 2018
Full-Year 2018 Highlights:
- Revenue of
$1.586 billion , representing 8.9% growth over 2017, on a pro forma basis - Operating loss of
($6.2) million , representing an improvement of$95.8 million over 2017, on a pro forma basis - Adjusted EBITDA of
$283.8 million , representing 15.7% growth over 2017, on a pro forma basis - Achieved savings during 2018 totaling
$64 million - Share buyback program remains in effect and 2,499,885 of common stock repurchased during 2018
“We had a solid 2018 and achieved our revised guidance for both revenue and Adjusted EBITDA. Our continued investment in developing industry specific and departmental solutions, as well as increased customer awareness, are showing good results. Digital NowSM made the difference! In 2018, we achieved full-year revenue growth of approximately
Financial information for 2018 contained in this press release, unless otherwise stated, is presented on an as reported basis in accordance with GAAP. Financial Information for the full-year 2017 is presented pro forma for the business combination of
Full Year 2018 Financial Highlights
- Revenue: Revenue of
$1.586 billion an increase of 8.9% from$1.456 billion in 2017, on a pro forma basis. Revenue for our Information and Transaction Processing Solutions (“ITPS”) segment was$1.274 billion , an increase of 12.6% year-over-year, driven primarily by growth in top customers, Digital NowSM model due to faster ramp up of contracts, growth investments and acquisitions offset by a decline in business with lower automation and project driven business. Healthcare Solutions (“HS”) revenue was$228.0 million , a decline of 2.4% year-over-year due to a decline in volumes from a single customer who lost a contract from one its customers, offset by a ramp up of new businesses, including the most recent healthcare acquisition which will position the segment for growth in 2019. Legal and Loss Prevention Services (“LLPS”) revenue was$84.6 million . Results in LLPS are event driven and were negatively impacted by projects that generated lower revenue.
- Net Loss: Net Loss for 2018, was
$162.5 million and represents an improvement of$79.9 million when compared to a pro forma net loss of$242.4 million in 2017. 2018 net loss was driven by$95.8 million higher operating income that was offset by an impairment charge of$48.1 million . Excluding the impairment charge, the Company would have reported a net loss of$114.4 million for 2018.
- Adjusted EBITDA: Adjusted EBITDA for the full-year 2018 was
$283.8 million , an increase of 15.7% from$245.2 million in 2017, on a pro forma basis. Adjusted EBITDA margin for 2018 was 17.9%, an increase of 110 basis points when compared to an Adjusted EBITDA margin of 16.8% in 2017, on a pro forma basis. The increase in 2018 Adjusted EBITDA and Adjusted EBITDA margin was primarily driven by revenue growth, the Company’s cost savings initiatives, and partially offset by investments the Company made for growth.
- Common Stock: As of
December 31, 2018 , there were 155,729,299 total shares of common stock outstanding which includes 5,586,344 shares reserved for outstanding preferred shares on an as-converted basis.
- Share buyback: During 2018, the Company repurchased 2,499,885 shares of common stock. Cumulative shares repurchased under the Company’s share buyback program total 2,549,185 since program inception.
$100 million contract won in Q4 2018, went liveJanuary 1, 2019 ; customer increased tenure by 2 years increasing its TCV to~$165 million .
- Launching SmartOfficeSM for growth in the front office automation offerings.
- ~9%(3) increase in revenue per FTE to
$72,000 , result ofExela technology driving automation. The increase in revenue per FTE is even higher, at 11% or$73,000 , when contributions from acquisitions are excluded.
~$130 million in total 2018 revenue growth with 51 net additional FTEs.
Americas split (Revenue / Headcount) 85% / 46% - Growth in revenue mainly driven by automation leading to a headcount decline yoy.
- EU split (Revenue / Headcount) 13% / 13% - Growth in revenue mainly driven by acquisition, far outpacing the headcount addition by over 6x.
- Rest of World split (Revenue / Headcount) 2% / 41% - Modest growth in headcount enabling global delivery and “right-shoring” model.
- Low customer concentration with top 100 customers, comprising 61% of revenue out of over 4,000 customers.
- 55% growth in revenue in
Europe during 2018.
- Customer retention rate 98%.
- Increase to 10 customers with over
$25 million in annual revenue, up from 6 customers inDecember 2017 .
- Increase to 259 customers with over
$1 million in annual revenue, up from 197 inDecember 2017 .
- Growth in revenue of 14% from top 200 customers, 12% growth excluding acquisitions.
- 2018 investment in business development and customer awareness showing visible results.
Fourth Quarter Ended
- Revenue: Revenue of
$399.6 million , an increase of 3.4% from$386.3 million in the fourth quarter of 2017. Revenue for our ITPS segment was$324.3 million , an increase of 7.6% year-over-year, driven primarily by growth in top customers, Digital NowSM model due to faster ramp up of contracts, growth investments and acquisitions offset by a decline in business with lower automation and project driven business. HS revenue was$56.3 million , a decline of 6.3% year-over-year mainly due to a decline in volumes from a single customer who lost a contract from one its customers, offset by a ramp up of new businesses, including the most recent healthcare acquisition which will position the segment for growth in 2019. LLPS revenue was$19.1 million . Results in LLPS are event driven and were negatively impacted by projects that generated lower revenue.
- Net Loss: Net Loss for the fourth quarter of 2018 was
$84.4 million , compared to a net loss of$58.7 million in the fourth quarter of 2017. Fourth quarter 2018 net loss was driven by$12.0 million higher operating income that was offset by an impairment charge of$48.1 million . Excluding the impairment charge, the Company would have reported a net loss of$36.3 million for the fourth quarter of 2018.
- AdjustedEBITDA: Adjusted EBITDA for the fourth quarter of 2018 was
$75.3 million an increase of 20.0% when compared to Adjusted EBITDA of$62.7 million in the fourth quarter of 2017. Adjusted EBITDA margin for the fourth quarter of 2018 was 18.8%, an increase of 260 basis points when compared to an Adjusted EBITDA margin of 16.2% in the fourth quarter of 2017. The increase in fourth quarter 2018 Adjusted EBITDA and Adjusted EBITDA margin was primarily driven by revenue growth, the Company’s cost savings initiatives, and partially offset by investments the Company made for growth.
- Capital Expenditures: Capital expenditures for the fourth quarter of 2018 was 3.1% of revenue compared to 2.9% on a year over year basis.
Balance Sheet and Liquidity
- At
December 31, 2018 , Exela’s total liquidity was$116 (4) million, measured as$44 million of cash, and an undrawn revolving credit facility of$100 million with$20.6 million reserved for letters of credit. Total net debt was$1.402 billion .
2019 guidance
- Revenue range
$1.66 billion to $1.70 billion , growth of approximately 5% - 7% year over year. - Adjusted EBITDA range
$305 million to $335 million , growth of approximately 7% - 18% year over year. - Capital expenditures range (as % of revenue) of 2% - 2.5%.
- Capital Allocation to be prioritized towards debt pre-payment.
- Reduction of net leverage ratio by 5% - 7%.
Note: Guidance is based on constant-currency.
Note on Outlook: The Company has not forecasted net income/(loss) on a forward-looking basis due to the high variability and difficulty in predicting certain items that affect GAAP net income/(loss). Adjusted EBITDA should not be used to predict net income/(loss) as the difference between the two measures is variable.
The above guidance is based on 2018 results.
Please refer to attached schedules for reconciliations. Due to rounding, numbers presented throughout this document may not add up precisely to the totals provided and percentages may not precisely reflect absolute figures.
(1) – EBITDA is a non-GAAP measure. A reconciliation of EBITDA is attached to this release.
(2) – Adjusted EBITDA is a non-GAAP measure. A reconciliation of Adjusted EBITDA is attached to this release.
(3) – Presented on a pro forma basis with acquisitions for the TTM period.
(4) – Total liquidity of
Filing of Form 12b-25
We intend to file a Form 12b-25 Notification of Late Filing with the
Earnings Conference Call and Audio Webcast
About
Find out more at www.exelatech.com
Follow
Follow
Preliminary Results
The financial results discussed herein are presented on a preliminary basis; final data will be included in Exela’s Annual Report on Form 10-K for the period ended
About Non-GAAP Financial Measures: This press release includes EBITDA and Adjusted EBITDA, each of which is a financial measure that is not prepared in accordance with U.S. generally accepted accounting principles (“GAAP”).
Forward-Looking Statements: Certain statements included in this press release are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “may”, “should”, “would”, “plan”, “intend”, “anticipate”, “believe”, “estimate”, “predict”, “potential”, “seem”, “seek”, “continue”, “future”, “will”, “expect”, “outlook” or other similar words, phrases or expressions. These forward-looking statements include statements regarding our industry, future events, the estimated or anticipated future results and benefits of the business combination of
Contact:
E: ir@exelatech.com
W: investors.exelatech.com
T: +1 972-821-5808
Consolidated Balance Sheets
For the years ended
(unaudited)
(in thousands of
December 31, | ||||||||
2018 | 2017 | |||||||
Assets | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ | 25,615 | $ | 39,000 | ||||
Restricted cash | 18,239 | 42,489 | ||||||
Accounts receivable, net of allowance for doubtful accounts of $4,359 and $3,725 respectively | 270,812 | 229,704 | ||||||
Inventories, net | 16,220 | 11,922 | ||||||
Prepaid expenses and other current assets | 25,015 | 24,596 | ||||||
Total current assets | 355,901 | 347,711 | ||||||
Property, plant and equipment, net | 132,986 | 132,908 | ||||||
Goodwill | 708,258 | 747,325 | ||||||
Intangible assets, net | 407,021 | 464,984 | ||||||
Deferred income tax assets | 16,225 | 9,019 | ||||||
Other noncurrent assets | 19,391 | 12,891 | ||||||
Total assets | $ | 1,639,782 | $ | 1,714,838 | ||||
Liabilities and Stockholders' Equity (Deficit) | ||||||||
Liabilities | ||||||||
Current liabilities | ||||||||
Accounts payable | $ | 99,853 | $ | 81,263 | ||||
Related party payables | 7,735 | 14,445 | ||||||
Income tax payable | 1,996 | 3,612 | ||||||
Accrued liabilities | 66,008 | 49,383 | ||||||
Accrued compensation and benefits | 54,583 | 46,925 | ||||||
Accrued interest | 49,071 | 55,102 | ||||||
Customer deposits | 34,235 | 31,656 | ||||||
Deferred revenue | 16,504 | 12,709 | ||||||
Obligation for claim payment | 56,002 | 42,489 | ||||||
Current portion of capital lease obligations | 17,498 | 15,611 | ||||||
Current portion of long-term debt | 29,237 | 20,565 | ||||||
Total current liabilities | 432,722 | 373,760 | ||||||
Long-term debt, net of current maturities | 1,306,423 | 1,276,094 | ||||||
Capital lease obligations, net of current maturities | 26,738 | 25,958 | ||||||
Pension liability | 25,269 | 25,496 | ||||||
Deferred income tax liabilities | 11,212 | 5,362 | ||||||
Long-term income tax liability | 3,024 | 3,470 | ||||||
Other long-term liabilities | 15,400 | 14,704 | ||||||
Total liabilities | 1,820,788 | 1,724,844 | ||||||
Commitment and Contingencies (Note 12) | ||||||||
Stockholders' equity (deficit) | ||||||||
Common stock, par value of $0.0001 per share; 1,600,000,000 shares authorized; 152,692,140 shares issued and 150,142,955 shares outstanding at December 31, 2018 and 150,578,451 shares issued and 150,529,151 outstanding at December 31, 2017 | 15 | 15 | ||||||
Preferred stock, par value of $0.0001 per share; 20,000,000 shares authorized; 4,569,233 shares issued and outstanding at December 31, 2018 and 6,194,233 shares issued or outstanding at December 31, 2017 | 1 | 1 | ||||||
Additional paid in capital | 482,018 | 482,018 | ||||||
Less: common stock held in treasury, at cost; 2,549,185 shares at December 31, 2018 and 49,300 shares at December 31, 2017 | (10,342 | ) | (249 | ) | ||||
Equity-based compensation | 41,731 | 34,085 | ||||||
Accumulated deficit | (678,563 | ) | (514,628 | ) | ||||
Accumulated other comprehensive loss: | ||||||||
Foreign currency translation adjustment | (6,565 | ) | (194 | ) | ||||
Unrealized pension actuarial losses, net of tax | (9,301 | ) | (11,054 | ) | ||||
Total accumulated other comprehensive loss | (15,866 | ) | (11,248 | ) | ||||
Total stockholders’ deficit | (181,006 | ) | (10,006 | ) | ||||
Total liabilities and stockholders’ deficit | $ | 1,639,782 | $ | 1,714,838 | ||||
Consolidated Statements of Operations for the Years ended
(unaudited)
(in thousands of
Year Ended December 31, | ||||||||||||
2018 | 2017 | 2016 | ||||||||||
Revenue | $ | 1,586,222 | $ | 1,152,324 | $ | 789,926 | ||||||
Cost of revenue (exclusive of depreciation and amortization) | 1,209,874 | 829,143 | 519,121 | |||||||||
Selling, general and administrative expenses | 184,651 | 220,955 | 130,437 | |||||||||
Depreciation and amortization | 145,485 | 98,890 | 79,639 | |||||||||
Impairment of goodwill and other intangible assets | 48,127 | 69,437 | — | |||||||||
Related party expense | 4,334 | 33,431 | 10,493 | |||||||||
Operating (loss) income | (6,249 | ) | (99,532 | ) | 50,236 | |||||||
Other expense (income), net: | ||||||||||||
Interest expense, net | 153,095 | 128,489 | 109,414 | |||||||||
Loss on extinguishment of debt | 1,067 | 35,512 | — | |||||||||
Sundry expense (income), net | (3,271 | ) | 2,295 | 712 | ||||||||
Other income, net | (3,030 | ) | (1,297 | ) | — | |||||||
Net loss before income taxes | (154,110 | ) | (264,531 | ) | (59,890 | ) | ||||||
Income tax (expense) benefit | (8,407 | ) | 60,246 | 11,787 | ||||||||
Net loss | $ | (162,517 | ) | $ | (204,285 | ) | $ | (48,103 | ) | |||
Dividend equivalent on Series A Preferred Stock related to beneficial conversion feature | - | (16,375 | ) | — | ||||||||
Cumulative dividends for Series A Preferred Stock | (3,655 | ) | (2,489 | ) | — | |||||||
Net loss attributable to common stockholders | $ | (166,172 | ) | $ | (223,149 | ) | $ | (48,103 | ) | |||
Loss per share: | ||||||||||||
Basic and diluted | $ | (1.09 | ) | $ | (2.08 | ) | $ | (0.75 | ) | |||
Consolidated Statements of Cash Flows
For the Years ended
(unaudited)
(in thousands of
Years ended December 31, | ||||||||||||
2018 | 2017 | 2016 | ||||||||||
Cash flows from operating activities | ||||||||||||
Net loss | $ | (162,517 | ) | $ | (204,285 | ) | $ | (48,103 | ) | |||
Adjustments to reconcile net loss | ||||||||||||
Depreciation and amortization | 145,485 | 98,890 | 79,639 | |||||||||
Fees paid in stock | - | 23,875 | — | |||||||||
HGM contract termination fee paid in stock | - | 10,000 | — | |||||||||
Original issue discount and debt issuance cost amortization | 10,913 | 12,280 | 13,684 | |||||||||
Impairment of goodwill and other intangible assets | 48,127 | 69,437 | — | |||||||||
Provision for doubtful accounts | 2,767 | 500 | 756 | |||||||||
Deferred income tax provision (benefit) | 3,352 | (66,723 | ) | (15,729 | ) | |||||||
Share-based compensation expense | 7,647 | 6,743 | 7,086 | |||||||||
Foreign currency remeasurement | (1,180 | ) | 1,382 | 193 | ||||||||
Loss on sale of assets | 2,095 | 399 | 2,245 | |||||||||
Fair value adjustment for interest rate swap | (2,540 | ) | (1,297 | ) | — | |||||||
Change in operating assets and liabilities, net of effect from acquisitions | ||||||||||||
Accounts receivable | (19,319 | ) | (4,832 | ) | 20,801 | |||||||
Prepaid expenses and other assets | (2,820 | ) | 2,628 | 4,969 | ||||||||
Accounts payable and accrued liabilities | 5,157 | 69,551 | 9,033 | |||||||||
Related party payables | (6,710 | ) | 4,907 | (2,427 | ) | |||||||
Net cash provided by operating activities | 30,457 | 23,455 | 72,147 | |||||||||
Cash flows from investing activities | ||||||||||||
Purchase of property, plant and equipment | (20,072 | ) | (14,440 | ) | (7,926 | ) | ||||||
Additions to internally developed software | (7,438 | ) | (7,843 | ) | (13,017 | ) | ||||||
Additions to outsourcing contract costs | (7,552 | ) | (10,992 | ) | (14,636 | ) | ||||||
Cash acquired in TransCentra acquisition | - | — | 3,351 | |||||||||
Proceeds from sale of Assets | 3,568 | 4,607 | 626 | |||||||||
Cash acquired in Quinpario reverse merger | - | 91 | — | |||||||||
Cash paid in acquisition, net of cash received | (34,810 | ) | (423,797 | ) | — | |||||||
Net cash used in investing activities | (66,304 | ) | (452,374 | ) | (31,602 | ) | ||||||
Cash flows from financing activities | ||||||||||||
Change in bank overdraft | - | (210 | ) | (1,331 | ) | |||||||
Loss on extinguishment of debt | 1,067 | 35,512 | — | |||||||||
Proceeds from issuance of stock | - | 204,417 | — | |||||||||
Cash received from Quinpario | - | 27,031 | — | |||||||||
Repurchase of Common Stock | (7,221 | ) | (249 | ) | — | |||||||
Proceeds from financing obligation | 11,557 | 3,116 | 5,429 | |||||||||
Contribution from Shareholders | - | 20,548 | — | |||||||||
Proceeds from new credit facility | 30,000 | 1,320,500 | — | |||||||||
Retirement of previous credit facilities | - | (1,055,736 | ) | — | ||||||||
Cash paid for debt issuance costs | (1,094 | ) | (39,837 | ) | — | |||||||
Cash paid for equity issue costs | (7,500 | ) | (149 | ) | — | |||||||
Borrowings from revolver and swing-line loan | 30,000 | 72,600 | 53,700 | |||||||||
Repayments from revolver and swing line loan | (30,000 | ) | (72,500 | ) | (53,200 | ) | ||||||
Principal payments on long-term obligations | (28,719 | ) | (39,316 | ) | (47,853 | ) | ||||||
Net cash provided by (used in) financing activities | (1,910 | ) | 475,727 | (43,255 | ) | |||||||
Effect of exchange rates on cash | 122 | 429 | (2,059 | ) | ||||||||
Net increase (decrease) in cash and cash equivalents | (37,635 | ) | 47,237 | (4,769 | ) | |||||||
Cash and cash equivalents | ||||||||||||
Beginning of period | 81,489 | 34,252 | 39,021 | |||||||||
End of period | $ | 43,854 | $ | 81,489 | $ | 34,252 | ||||||
Supplemental cash flow data: | ||||||||||||
Income tax payments, net of refunds received | $ | 7,827 | $ | 5,711 | $ | 3,771 | ||||||
Interest paid | 146,076 | 69,622 | 96,166 | |||||||||
Noncash investing and financing activities: | ||||||||||||
Assets acquired through capital lease arrangements | 14,920 | 6,973 | 11,925 | |||||||||
Leasehold improvements funded by lessor | 1,565 | 146 | 5,186 | |||||||||
Issuance of common stock as consideration for Novitex | - | 244,800 | — | |||||||||
Accrued capital expenditures | 2,820 | 1,621 | 580 | |||||||||
Dividend equivalent on Series A Preferred Stock | - | 16,375 | — | |||||||||
Liability assumed of Quinpario | - | 4,672 | — | |||||||||
Schedule 1: Fourth Quarter 2017 vs. Fourth Quarter 2018 Financial Performance
(unaudited)
$ in millions | Q4'17 | Q4'18 | Change ($) | |||||
Information and Transaction Processing Solutions | 301.5 | 324.3 | 22.8 | |||||
Healthcare Solutions | 60.1 | 56.3 | (3.8 | ) | ||||
Legal and Loss Prevention Services | 24.7 | 19.1 | (5.6 | ) | ||||
Total Revenue | 386.3 | 399.6 | 13.4 | |||||
% change | 3.4 | % | ||||||
Cost of revenue (exclusive of depreciation and amortization) | 289.9 | 306.2 | 16.3 | |||||
Gross profit | 96.4 | 93.5 | (2.9 | ) | ||||
% change | -3.0 | % | ||||||
as a % of revenue | 25.0 | % | 23.4 | % | ||||
SG&A | 48.3 | 47.4 | (0.9 | ) | ||||
Depreciation and amortization | 28.1 | 36.1 | 7.9 | |||||
Impairment of goodwill and other intangible assets | 69.4 | 48.1 | (21.3 | ) | ||||
Related party expense | 1.7 | 1.1 | (0.6 | ) | ||||
Operating (loss) income | (51.2 | ) | (39.2 | ) | 12.0 | |||
as a % of revenue | -13.3 | % | -9.8 | % | ||||
Interest expense, net | 36.7 | 38.2 | 1.5 | |||||
Loss on extinguishment of debt | - | - | - | |||||
Sundry expense (income) & Other income, net | (2.0 | ) | 3.5 | 5.4 | ||||
Net loss before income taxes | (86.0 | ) | (80.9 | ) | 5.1 | |||
Income tax expense (benefit) | (27.3 | ) | 3.5 | 30.8 | ||||
Net income (loss) | (58.7 | ) | (84.4 | ) | (25.7 | ) | ||
as a % of revenue | -15.2 | % | -21.1 | % | ||||
Depreciation and amortization | 28.1 | 36.1 | 7.9 | |||||
Interest expense, net | 36.7 | 38.2 | 1.5 | |||||
Income tax expense (benefit) | (27.3 | ) | 3.5 | 30.8 | ||||
EBITDA | (21.1 | ) | (6.6 | ) | 14.5 | |||
as a % of revenue | -5.5 | % | -1.7 | % | ||||
EBITDA Adjustments | ||||||||
1 | Transaction and integration costs | 2.4 | 2.0 | (0.3 | ) | |||
2 | Optimization and restructuring expenses | 11.0 | 21.2 | 10.2 | ||||
3 | Gain / loss on derivative instruments | (1.3 | ) | 2.9 | 4.2 | |||
4 | Other Charges | 71.8 | 55.8 | (16.0 | ) | |||
Adjusted EBITDA | 62.7 | 75.3 | 12.6 | |||||
% change | 20.0 | % | ||||||
as a % of revenue | 16.2 | % | 18.8 | % | ||||
Schedule 2: Pro Forma 2017(1) vs. 2018 Financial Performance
(unaudited)
$ in millions | FY17 | FY18 | Change ($) | ||||||
Information and Transaction Processing Solutions | 1,131.0 | 1,273.6 | 142.6 | ||||||
Healthcare Solutions | 233.6 | 228.0 | (5.6 | ) | |||||
Legal and Loss Prevention Services | 91.6 | 84.6 | (7.1 | ) | |||||
Total Revenue | 1,456.3 | 1,586.2 | 129.9 | ||||||
% change | 8.9 | % | |||||||
Cost of revenue (exclusive of depreciation and amortization) | 1,079.9 | 1,209.9 | 130.0 | ||||||
Gross profit | 376.4 | 376.3 | (0.0 | ) | |||||
% change | 0.0 | % | |||||||
as a % of revenue | 25.8 | % | 23.7 | % | |||||
SG&A | 255.8 | 184.7 | (71.1 | ) | |||||
Depreciation and amortization | 119.5 | 145.5 | 26.0 | ||||||
Impairment of goodwill and other intangible assets | 69.4 | 48.1 | (21.3 | ) | |||||
Related party expense | 33.7 | 4.3 | (29.4 | ) | |||||
Operating (loss) income | (102.1 | ) | (6.2 | ) | 95.8 | ||||
as a % of revenue | -7.0 | % | -0.4 | % | |||||
Interest expense, net | 153.4 | 153.1 | (0.3 | ) | |||||
Loss on extinguishment of debt | 53.0 | 1.1 | (51.9 | ) | |||||
Sundry expense (income) & Other income, net | 1.1 | (6.3 | ) | (7.4 | ) | ||||
Net loss before income taxes | (309.6 | ) | (154.1 | ) | 155.5 | ||||
Income tax expense (benefit) | (67.2 | ) | 8.4 | 75.6 | |||||
Net income (loss) | (242.4 | ) | (162.5 | ) | 79.9 | ||||
as a % of revenue | -16.6 | % | -10.2 | % | |||||
Depreciation and amortization | 119.5 | 145.5 | 26.0 | ||||||
Interest expense, net | 153.4 | 153.1 | (0.3 | ) | |||||
Income tax expense (benefit) | (67.2 | ) | 8.4 | 75.6 | |||||
EBITDA | (36.7 | ) | 144.5 | 181.1 | |||||
as a % of revenue | -2.5 | % | 9.1 | % | |||||
EBITDA Adjustments | |||||||||
1 | Transaction and integration costs | 99.0 | 4.1 | (94.8 | ) | ||||
2 | Optimization and restructuring expenses | 47.9 | 68.2 | 20.3 | |||||
3 | Gain / loss on derivative instruments | (1.3 | ) | (1.9 | ) | (0.6 | ) | ||
4 | Other Charges | 136.3 | 69.0 | (67.3 | ) | ||||
Adjusted EBITDA | 245.2 | 283.8 | 38.6 | ||||||
% change | 15.7 | % | |||||||
as a % of revenue | 16.8 | % | 17.9 | % | |||||
(1) Net loss for the period is presented on the basis of the previous debt structure of the respective standalone companies that became
Schedule 3: 2017 Adjusted EBITDA Reconciliation
FY2017(1) | ||||||||||||
$ in millions | As Reported |
Novitex |
Pro Forma |
|||||||||
Revenue | $ | 1,152.3 | $ | 304.0 | $ | 1,456.3 | ||||||
Cost of revenue (exclusive of depreciation and amortization) | 829.1 | 250.8 | 1,079.9 | |||||||||
Selling, general and administrative expenses (Including related party) | 254.4 | 35.1 | 289.5 | |||||||||
Depreciation and amortization | 98.9 | 20.6 | 119.5 | |||||||||
Impairment of goodwill and other intangible assets | 69.4 | 0.0 | 69.4 | |||||||||
Operating income (loss) | (99.5 | ) | (2.5 | ) | (102.1 | ) | ||||||
Interest expense, net | 128.5 | 24.9 | 153.4 | |||||||||
Loss / (Gain) on extinguishment of debt | 35.5 | 17.5 | 53.0 | |||||||||
Sundry expense & other income, net | 1.0 | 0.0 | 1.1 | |||||||||
Net loss before income taxes | (264.5 | ) | (45.0 | ) | (309.6 | ) | ||||||
Income tax (benefit) expense | (60.2 | ) | (6.9 | ) | (67.2 | ) | ||||||
Net loss | $ | (204.3 | ) | $ | (38.0 | ) | $ | (242.4 | ) | |||
Add: | ||||||||||||
Taxes | (60.2 | ) | (6.9 | ) | (67.2 | ) | ||||||
Interest expense | 128.5 | 24.9 | 153.4 | |||||||||
Depreciation and amortization | 98.9 | 20.6 | 119.5 | |||||||||
EBITDA | $ | (37.2 | ) | $ | 0.6 | $ | (36.7 | ) | ||||
Transaction related costs | 88.9 | 10.0 | 99.0 | |||||||||
Optimization and restructuring expenses | 42.5 | 5.4 | 47.9 | |||||||||
(Gain) / loss on derivative instruments | (1.3 | ) | 0.0 | (1.3 | ) | |||||||
Other Charges | 115.8 | 20.5 | 136.3 | |||||||||
Adjusted EBITDA | $ | 208.8 | $ | 36.5 | $ | 245.2 | ||||||
(1) Net loss for the period is presented on the basis of the previous debt structure of the respective standalone companies that became
Source: Exela Technologies, Inc.